PRESS RELEASE published on 10/30/2025 at 14:45, 3 months 22 days ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses a 1.67% interest in Mural Oncology plc. Form 8.3 filed with the Irish Takeover Panel on 30-Oct-2025 Form 8.3 Irish Takeover Panel Vanguard Group Interest Disclosure Mural Oncology Plc
PRESS RELEASE published on 10/30/2025 at 14:43, 3 months 22 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.05% interest in JTC plc's 1p ordinary shares. Dealing and disclosure details provided as per Rule 8.3 of the Takeover Code Rule 8.3 Takeover Code Vanguard Group 1p Ordinary Shares JTC Plc
PRESS RELEASE published on 10/30/2025 at 14:42, 3 months 22 days ago Form 8.3 - The Vanguard Group, Inc.: Just Group plc The Vanguard Group, Inc. discloses 5.37% stake in Just Group plc as of 29 October 2025. Purchase of 83,330 10p ordinary shares at 2.13 GBP per unit The Vanguard Group Inc. Stake Disclosure 10p Ordinary Shares Purchase Disclosure Just Group Plc
PRESS RELEASE published on 10/30/2025 at 14:40, 3 months 22 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses public position details for Spire Healthcare Group plc in accordance with Rule 8.3 of the Takeover Code on 30-Oct-2025 Disclosure The Vanguard Group Rule 8.3 Takeover Code Spire Healthcare Group Plc
PRESS RELEASE published on 10/30/2025 at 14:39, 3 months 22 days ago Form 8.3 - The Vanguard Group, Inc.: Big Yellow Group plc The Vanguard Group, Inc. discloses 5.55% stake in Big Yellow Group plc as of 29 Oct 2025 The Vanguard Group, Inc. Financial Disclosure Stock Market Stake Disclosure Big Yellow Group Plc
PRESS RELEASE published on 10/30/2025 at 14:38, 3 months 22 days ago Form 8.3 - The Vanguard Group, Inc.: Alpha Group International plc Form 8.3 disclosure by The Vanguard Group, Inc. regarding Alpha Group International plc on 30-Oct-2025 Securities Form 8.3 Disclosure The Vanguard Group Alpha Group International
PRESS RELEASE published on 10/30/2025 at 14:36, 3 months 22 days ago Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc The Vanguard Group, Inc. discloses a 5.36% stake in Greencore Group plc. Additional disclosure for Bakkavor Group plc. Purchase of 39,951 securities at 2.38 GBP per unit Securities Disclosure Vanguard Group Bakkavor Group Greencore Group
PRESS RELEASE published on 10/30/2025 at 14:35, 3 months 22 days ago Form 8.3 - The Vanguard Group, Inc.: Bakkavor Group plc The Vanguard Group, Inc. discloses 1.66% ownership in Bakkavor Group plc. Purchase of 2,316 2p ordinary shares at 2.22 GBP per unit The Vanguard Group Stock Purchase Ownership Disclosure Financial Disclosure Bakkavor Group Plc
PRESS RELEASE published on 10/30/2025 at 14:34, 3 months 22 days ago Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The The Vanguard Group, Inc. discloses 4.97% ownership of Unite Group plc. Recent purchases at 5.73 GBP and 5.76 GBP per unit disclosed The Vanguard Group Ownership Disclosure Stock Transactions Purchase Disclosure Unite Group Plc
PRESS RELEASE published on 10/30/2025 at 14:32, 3 months 22 days ago Form 8.3 - The Vanguard Group, Inc.: Empiric Student Property plc The Vanguard Group, Inc. discloses a 1.88% stake in Empiric Student Property plc as of 29 October 2025 through Form 8.3 filing Form 8.3 Disclosure Vanguard Group Stake Empiric Student Property Plc
Published on 02/21/2026 at 00:45, 1 day 5 hours ago Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Published on 02/21/2026 at 00:30, 1 day 5 hours ago Redwood AI Corp. Announces Engagement for IR Services
Published on 02/20/2026 at 23:00, 1 day 7 hours ago Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/20/2026 at 22:17, 1 day 8 hours ago Organto Foods Completes Warrant Exercise Incentive Program
Published on 02/21/2026 at 12:00, 18 hours 27 minutes ago Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Published on 02/20/2026 at 18:36, 1 day 11 hours ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 1 day 11 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:00, 1 day 12 hours ago Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations
Published on 02/20/2026 at 09:28, 1 day 20 hours ago Statement about the number of shares composing the share capital and the number of voting rights as of January 31, 2026
Published on 02/20/2026 at 07:30, 1 day 22 hours ago Announcement of share buyback in the context of a share purchase plan
Published on 02/20/2026 at 07:30, 1 day 22 hours ago EURAZEO COMPLETES THE SALE OF EX NIHILO TO L CATTERTON
